Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 142   

Articles published

NVS 90.15 +0.91 (1.02%)
price chart
Pharma Stocks To Look Out For This Week
The US Food and Drug Administration (FDA) is also expected to release briefs for the Advisory Committee's meeting next week to give recommendations on Novartis AG (ADR)'s (NVS) secukinumab and Vertex Pharmaceuticals Incorporated's (VRTX) ...
Pharma Stocks Alert: Bristol-Myers Squibb Co (NYSE:BMY), Novartis AG (ADR ...
Global biopharmaceutical company Bristol-Myers Squibb Co (NYSE:BMY) said Monday that it has partnered with Novartis AG (ADR) (NYSE:NVS) to conduct a clinical trial evaluating the safety, tolerability and preliminary efficacy of combining BMY's ...
Related articles »  
Novartis AG (ADR)(NYSE:NVS) Drug Signifor LAR To Be Used For Treating ...
Boston, MA 09/29/2014 (wallstreetpr) - According to reports, Novartis AG (ADR)(NYSE:NVS)'s drug Signifor LAR has got the recommendation of CHMP for the approval of EU.
Related articles »  
News Review: Novartis AG (ADR) (NYSE:NVS), Citrix Systems, Inc. (NASDAQ ...
Houston, TX - Sep 24, 2014 - (Techsonian) - Novartis AG (ADR) (NYSE:NVS) declared, in the largest heart failure study to date,1,5 that its investigational heart failure medicine, LCZ696, was superior to the ACE-inhibitor enalapril on key endpoints.
Healthcares Sector Unexpected Mover:AbbVieInc (NYSE:ABBV ...
Reuters reported that, Last year the bosses of drug manufacturer Roche and Novartis AG (ADR) (NYSE:NVS) both earned more than 13 million Swiss francs $13.6 million, according to a research published inthe last week, 18 months after the Swiss voted for ...
Health stocks in focus: Novartis AG (NYSE:NVS), Sanofi SA (ADR) (NYSE:SNY ...
Novartis AG (NYSE:NVS) announced Friday that the European Medicines Agency (EMA) committee has given positive recommendations for its drug� Signifor LAR (pasireotide)� to the European Union (EU).
Traders Watch: Novartis AG (ADR) (NYSE:NVS), BlackBerry Ltd (NASDAQ ...
Novartis AG (ADR)(NYSE:NVS) noted that Signifor LAR presentation before EU is imminent following the Committee for Medicinal Products for Human Use(CHMP) recommendation.
Related articles »  
Active Stocks: Novartis AG (ADR) (NYSE:NVS), Doral Financial Corp. (NYSE ...
Dallas, Texas, 09/24/2014 (ustrademedia) - In July 2014, Novartis AG (ADR)(NYSE:NVS) subsidiary Sandoz Inc., had announced an agreement of distributorship and commercial sale with Anacor Pharmaceuticals Inc (NYSE:ANAC) product, for of KERYDIN ...
Traders Recap- Novartis AG (ADR) (NYSE:NVS), Royal Dutch Shell plc (ADR ...
Las Vegas, NV �October 06, 2014� (TechSonian) - Novartis AG (ADR)(NYSE:NVS) posted that the Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led ...
Amgen, Inc. (NASDAQ:AMGN), Novartis AG (ADR) (NYSE:NVS), Merck & Co ...
Dallas, Texas, 09/22/2014 (ustrademedia) - Amgen, Inc.(NASDAQ:AMGN) is but one of the few targeted by companies such as Novartis to imitate and sell, cheaper versions of block buster biotechnology drugs such as Amgen's cancer drug Neupogen, which ...